Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

About Us

Genomics and Population Health 2005 SNPets from CDC


In January 2004, CDC developed a summary briefing book to document its priorities, accomplishments in 2004, and future directions in human genomics.

NHANES Working Group
 A CDC-wide team is currently collaborating with the National Cancer Institute to measure population variation in selected genes using stored DNA samples collected during the third National Health and Nutrition Examination Survey (NHANES) III.

National Birth Defects Prevention Study (NBDPS)
 This ongoing case-control study has collected DNA samples by using cheek swabs from enrolled children and their parents, with over 5,000 samples received in 2004.

Stroke Prevention in Young Women Study
 This collaboration of CDC, the University of Maryland and 59 hospitals in the Baltimore– Washington, D.C. area recently published a study of ischemic stroke in relation to genes in the thrombomodulin-protein C pathway.

Surveillance for Duchenne/Becker Muscular Dystrophy (DBMD)
 CDC is developing an approach to single gene disorders based on surveillance and improved screening, diagnosis and services, beginning with the Muscular Dystrophy Surveillance Tracking and Research Network (MD Starnet)in Arizona, Colorado, Iowa, and western New York state.

Molecular Signatures of Cervical Neoplasia
As part of the National Cancer Institute’s (NCI) Early Detection Research Network, CDC has detected and validated biomarkers that can be used to improve the sensitivity and specificity of cervical cancer screening.

Searching for a Flavivirus
Susceptibility or Resistance Gene in West Nile Virus (WNV) Infection CDC scientists are currently collaborating with Georgia State University to search for a flavivirus susceptibility/resistance gene in persons who were hospitalized for WNV disease during the 2003 WNV outbreak in Colorado.

The Role of Host Genetic Polymorphisms in Susceptibility to M. Tuberculosis Infection and Progression to TB Disease
CDC is working to identify genetic risk factors for susceptibility to TB. These could help TB programs in other countries target costly interventions to the 10% of exposed persons truly at risk of developing TB.

Genetics of Kidneys in Diabetes (GoKinD) Study
CDC is developing a repository of DNA samples to study kidney disease in adults with type 1 diabetes as part of a study sponsored by the Juvenile Diabetes Research Foundation, in collaboration with the Joslin Diabetes Center and George Washington University.

Chronic Beryllium Disease (CBD)
A sophisticated PCR-DNA sequencing assay has been developed to identify more precisely specific haplotypes associated with susceptibility to CBD.

Johnston County Osteoarthritis Project
CDC and the University of North Carolina are conducting a community-based cohort study of risk factors, including genetics, for osteoarthritis in a rural population.

The Human Genome Epidemiology Network (HuGeNet™) co-sponsored a workshop on meta-analysis of gene-disease association data with the Public Health Genetics Unit in Cambridge, U.K.

Newborn Screening for Cystic Fibrosis
A report with recommendations for newborn screening for cystic fibrosis was published in the MMWR in October 2004, summarizing results of a workshop co-sponsored by CDC and the Cystic Fibrosis Foundation.

Analysis of Genetic Risk Factors for Fatal Influenza in Children
CDC is conducting a case-control study integrated with multi-state population-based surveillance for influenza-related hospitalizations in children during the 2004-2005 season to identify genetic variants that may put certain children at a greater risk of mortality associated with influenza.

Rare Disease Genetic Testing
In collaboration with other HHS agencies, professional organizations, patient advocacy groups, and Emory University, CDC convened a conference: “Promoting Quality Laboratory Testing for Rare Diseases: Keys to Ensuring Quality Genetic Testing.”

Influence of Host Genetics on Virological Failure of Highly Active Anti-Retroviral Therapy (HAART)
CDC investigators are studying the effect of host genetics on virological failure of HAART using a HIV-infected adult cohort with well-documented treatment history.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP™)
CDC has assembled an independent, non-Federal working group of experts in epidemiology, genomics, public health, laboratory practice, medicine and health services to demonstrate an evidence-based review process for genetic tests in transition from research to clinical application.

Prevalence of Gene Variants Coding for Enzymes Involved in Nicotine and Carcinogen Metabolism
CDC will genotype approximately 7,300 samples from the NHANES III DNA Bank for genes associated with nicotine metabolism.

Genetic and Environmental Factors in Brain Cancer
CDC is conducting a population-based case-control study to assess potential genetic susceptibility factors in the excess risk of brain cancer observed among persons working in agriculture.



Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd.
    Atlanta, GA 30333 USA
    800-CDC-INFO (800-232-4636)
  • Additional information for Public Health Genomics is available on our contact page. The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #